0.9333
price up icon0.93%   0.00825
 
loading
전일 마감가:
$0.925
열려 있는:
$0.9
하루 거래량:
222.50K
Relative Volume:
0.55
시가총액:
$20.43M
수익:
-
순이익/손실:
$-25.56M
주가수익비율:
-0.1795
EPS:
-5.2
순현금흐름:
$-19.35M
1주 성능:
-12.75%
1개월 성능:
-10.23%
6개월 성능:
-53.32%
1년 성능:
-77.58%
1일 변동 폭
Value
$0.88
$0.96
1주일 범위
Value
$0.88
$1.09
52주 변동 폭
Value
$0.62
$7.50

Biovie Inc Stock (BIVI) Company Profile

Name
명칭
Biovie Inc
Name
전화
775-888-3162
Name
주소
680 W NYE LANE, CARSON CITY
Name
직원
14
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
BIVI's Discussions on Twitter

BIVI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BIVI
Biovie Inc
0.9364 20.43M 0 -25.56M -19.35M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.31 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
538.09 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
323.01 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
548.00 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.32 28.51B 3.81B -644.79M -669.77M -6.24

Biovie Inc Stock (BIVI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-07-22 개시 Cantor Fitzgerald Overweight
2021-01-15 개시 B. Riley Securities Buy

Biovie Inc 주식(BIVI)의 최신 뉴스

pulisher
Jun 16, 2025

New to The Street’s Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Oklahoman

Jun 16, 2025
pulisher
Jun 16, 2025

New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lubbock Avalanche-Journal

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Acquires Shares of 122,619 BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Invests $28,000 in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in BioVie LawsuitBIVI - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 07, 2025

New to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and Commercialville - The Oklahoman

Jun 07, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Buys Shares of 16,878 BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 02, 2025

The Law Offices of Vincent Wong Remind BioVie Investors of a Lead Plaintiff Deadline of March 19, 2024 - marketscreener.com

Jun 02, 2025
pulisher
May 29, 2025

Investors' Lawsuit Against BioVie Moves to Evidence Review — Here's How to Recover Losses - TradingView

May 29, 2025
pulisher
May 28, 2025

Transcript : BioVie Inc.Special Call - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

BioVie (NASDAQ:BIVI) Trading 1.9% Higher – Time to Buy? - Defense World

May 28, 2025
pulisher
May 18, 2025

FY2025 EPS Estimates for BioVie Raised by Analyst - Defense World

May 18, 2025
pulisher
May 15, 2025

BioVie Inc. Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BI - GuruFocus

May 15, 2025
pulisher
May 15, 2025

BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BIVI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

New Long COVID Treatment Hope: BioVie Launches Phase 2 Trial for 20M+ US Patients with Brain Fog - Stock Titan

May 15, 2025
pulisher
May 15, 2025

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - The Manila Times

May 15, 2025
pulisher
May 14, 2025

BioVie (BIVI) To Host Key Opinion Leader Event Discussing Parkin - GuruFocus

May 14, 2025
pulisher
May 14, 2025

BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of - GuruFocus

May 14, 2025
pulisher
May 14, 2025

BioVie to host KOL event on Phase 2 study of bezisterim - TipRanks

May 14, 2025
pulisher
May 14, 2025

BioVie Inc. to Host Virtual KOL Event Discussing Parkinson’s Disease and Update on Phase 2 SUNRISE-PD Trial for Bezisterim - Nasdaq

May 14, 2025
pulisher
May 14, 2025

BioVie to Host Virtual KOL Event to Discuss the Phase 2 - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Biovie Inc. to Host Virtual Kol Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Critical Survey: Coya Therapeutics (NASDAQ:COYA) vs. BioVie (NASDAQ:BIVI) - Defense World

May 14, 2025
pulisher
May 12, 2025

BIOVIE Earnings Results: $BIVI Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

BIOVIE INC. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Lost Money on BioVie Inc.(BIVI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

May 12, 2025
pulisher
May 11, 2025

BioVie (BIVI) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

Investors who lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

BioVie Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 19, 2024 to Discuss Your RightsBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Investors who lost money on BioVie Inc.(BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Levi & Korsinsky Reminds BioVie Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024BIVI - ACCESS Newswire

May 10, 2025
pulisher
May 09, 2025

Shareholders that lost money on BioVie Inc.(BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

INVESTOR ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Shareholders that lost money on BioVie Inc. (BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 09, 2025
pulisher
May 08, 2025

Shareholders that lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out - ACCESS Newswire

May 08, 2025
pulisher
May 07, 2025

BioVie to Present Rationale and Design of Phase 2 - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

BioVie (BIVI) Showcases Parkinson's Trial at Global Conference | BIVI Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Market Insights: BioVie Inc (BIVI)’s Notable Gain of 1.75, Closing at 1.16 - DWinneX

May 07, 2025

Biovie Inc (BIVI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.77
price up icon 0.56%
$35.82
price down icon 0.49%
$21.09
price down icon 0.87%
$97.65
price down icon 3.11%
$107.93
price up icon 1.34%
biotechnology ONC
$243.32
price up icon 0.52%
자본화:     |  볼륨(24시간):